A Drug-Drug Interaction Study of Omeprazole and PA21
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of this study is to determine if Omeprazole is affected by PA21.
Key facts
- Study ID
- NCT01452906
- Run by
- Vifor Pharma
- People needed
- 45
- Starts
- 2011-09-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2011-12-12
Who can join
Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy Volunteers
- Written informed consent
You may not qualify if…
- No significant medical conditions
- Pregnancy
Where it is running
- ACRI - Phase 1 — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.